Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Positive phase III trial results reported for phosphate binder

Jan. 9, 1997

P&U files for European approval of urinary incontinence Rx

Jan. 9, 1997

Watson's first NDA product approved

Jan. 3, 1997

Anti-TGF-beta MAbs from Celtrix

Dec. 31, 1996

LJP licenses rights to drug for lupus

Dec. 30, 1996

Nonsteroidal 5alpha-reductase inhibitors reported by Kyowa Hakko

Dec. 24, 1996

Agents for urinary incontinence reported by Dainippon

Dec. 23, 1996

Licensees sought for PKD1 gene and mutations

Dec. 17, 1996

More terazosin clinical data reported

Dec. 17, 1996

New diuretics reported by Pharmacia & Upjohn

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...